Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Total
Private Placement
Equity Line Of Credit
Preferred Stock
Common Stock
Common Stock
Private Placement
Common Stock
Equity Line Of Credit
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Equity Line Of Credit
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at Dec. 31, 2021 $ 14,579,048     $ 0 $ 3,166     $ 135,541,662     $ (120,879,349) $ (86,431)
Balance (in shares) at Dec. 31, 2021       7 316,599              
Stock-Based Compensation 215,921             215,921        
Foreign Currency Translation Adjustment 27,839                     27,839
Net Loss (3,565,014)                   (3,565,014)  
Balance at Mar. 31, 2022 11,257,794     $ 0 $ 3,166     135,757,583     (124,444,363) (58,592)
Balance (in shares) at Mar. 31, 2022       7 316,599              
Balance at Dec. 31, 2022 11,407,600     $ 0 $ 17,986     146,035,314     (134,462,959) (182,741)
Balance (in shares) at Dec. 31, 2022       7 1,796,472              
Stock-Based Compensation 135,941             135,941        
Issuance of Common Stock   $ 115,715 $ 98,960     $ 528 $ 200   $ 115,187 $ 98,760    
Issuance of Common Stock (in shares)           52,798 20,000          
Issuance of Common Stock from Warrant Exercises 298,500       $ 500     298,000        
Issuance of Common Stock from Warrant Exercises (in shares)         50,000              
Foreign Currency Translation Adjustment (32,671)                     (32,671)
Net Loss (1,868,536)                   (1,868,536)  
Balance at Mar. 31, 2023 $ 10,155,509     $ 0 $ 19,214     $ 146,683,202     $ (136,331,495) $ (215,412)
Balance (in shares) at Mar. 31, 2023       7 1,919,270